Loading…
Rezolute, Inc. is projected to rise to $5.91 by 2027, a +78% move from its current price of $3.32. RZLT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.22 | $3.32 | $3.43 | +0.09% |
| May 30 | $3.19 | $3.33 | $3.47 | +0.19% |
| May 31 | $3.16 | $3.33 | $3.51 | +0.28% |
| Jun 1 | $3.14 | $3.33 | $3.54 | +0.38% |
| Jun 2 | $3.12 | $3.34 | $3.57 | +0.47% |
| Jun 3 | $3.10 | $3.34 | $3.60 | +0.57% |
| Jun 4 | $3.08 | $3.34 | $3.62 | +0.67% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.08 | $3.34 | $3.62 | +0.67% |
| Week 2 | $3.00 | $3.36 | $3.77 | +1.34% |
| Week 3 | $2.95 | $3.39 | $3.89 | +2.01% |
| Week 4 | $2.90 | $3.41 | $4.00 | +2.69% |
| Week 5 | $2.87 | $3.43 | $4.11 | +3.37% |
| Week 6 | $2.84 | $3.45 | $4.21 | +4.06% |
| Week 7 | $2.81 | $3.48 | $4.30 | +4.75% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Rezolute, Inc. is a late-stage rare disease company focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism.
Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California. It was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017.
Rezolute, Inc. (RZLT) is a healthcare company. The stock trades at $3.25 per share and has a market cap of $312.95M. Its rank is 3483. The current price sits at $3.25, with the multi-year forecast projecting upside ahead. From 2027 onward, the average price is projected to rise to higher levels, with bullish sentiment starting in 2027.
A major floor 28.3% below — a decisive break under it would weaken the trend.
The nearest floor, 7.5% below — buyers have tended to step in here.
The nearest ceiling, 8.1% above — a clean break opens room to run.
A major ceiling 15.9% above — clearing it would confirm fresh momentum.
Key RZLT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RZLT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.29 | Buy | $3.29 | Buy |
| MA 10 | $3.28 | Buy | $3.27 | Buy |
| MA 20 | $3.25 | Buy | $3.26 | Buy |
| MA 50 | $3.18 | Buy | $3.28 | Buy |
| MA 100 | $3.12 | Buy | $3.68 | Sell |
| MA 200 | $5.43 | Sell | $4.34 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.76 | Neutral |
| Stoch RSI (14) | 70.37 | Neutral |
| CCI (20) | 64.69 | Neutral |
| Williams %R (14) | -25.81 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 3.43 | Buy |
| Bollinger %B (20,2) | 0.71 | Neutral |
| Stochastic %K (14) | 74.19 | Neutral |
| TRIX (15) | 0.03 | Buy |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 50.74 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 3.31 | Buy |
| ADX (14) | 7.15 | Neutral |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is bullish overall.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.91 | $3.32 | $5.34 | 0% | Neutral | |
| $4.64 | $5.91 | $8.01 | +78% | Bullish | |
| $5.90 | $7.76 | $10.94 | +134% | Bullish | |
| $6.48 | $8.74 | $12.70 | +163% | Bullish | |
| $7.24 | $9.99 | $14.90 | +201% | Bullish | |
| $8.06 | $11.35 | $17.32 | +242% | Bullish | |
| $9.02 | $12.96 | $20.18 | +290% | Bullish | |
| $12.13 | $17.75 | $28.15 | +435% | Bullish | |
| $13.99 | $20.84 | $33.62 | +528% | Bullish | |
| $15.05 | $22.79 | $37.36 | +586% | Bullish | |
| $25.06 | $41.00 | $71.80 | +11.3x | Bullish | |
| $46.57 | $87.18 | $168.05 | +25.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.91 | $3.32 | $3.94 | +0.00% |
| June 2026 | $3.03 | $3.57 | $4.31 | +7.47% |
| July 2026 | $3.05 | $3.62 | $4.43 | +1.45% |
| August 2026 | $3.08 | $3.69 | $4.57 | +1.91% |
| September 2026 | $3.26 | $3.92 | $4.91 | +6.38% |
| October 2026 | $3.35 | $4.06 | $5.12 | +3.46% |
| November 2026 | $3.31 | $4.03 | $5.12 | -0.68% |
| December 2026 | $3.42 | $4.18 | $5.34 | +3.59% |
Click any year to see its month-by-month RZLT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, RZLT is projected to trade between $1.91 and $5.34, averaging $3.32 — a potential gain of 0% from today's $3.32. A consolidation phase looks the most probable path here.
Rezolute, Inc.'s 2027 outlook centres on $5.91, within a $4.64 to $8.01 range. That is up +78% on the projected 2026 average. That marks a +78% change versus current levels. Momentum favours further upside here.
By 2028, RZLT could reach as high as $10.94, with a base case around $7.76 and support toward $5.90 — roughly +134% from $3.32. Buyers look set to stay in control over this stretch.
Expect RZLT to range from $6.48 to $12.70 through 2029. The $8.74 average target implies a +163% move from current prices. That is up +13% on the projected 2028 average. Momentum favours further upside here.
The RZLT price prediction for 2030 points to an average of $9.99 (low $7.24, high $14.90) — a potential gain of +201% on today's $3.32. Buyers look set to stay in control over this stretch.
In 2031, RZLT is projected to trade between $8.06 and $17.32, averaging $11.35 — a potential gain of +242% from today's $3.32. That is up +14% on the projected 2030 average. Momentum favours further upside here.
Rezolute, Inc.'s 2032 outlook centres on $12.96, within a $9.02 to $20.18 range. That is up +14% on the projected 2031 average. That marks a +290% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, RZLT could reach as high as $28.15, with a base case around $17.75 and support toward $12.13 — roughly +435% from $3.32. Momentum favours further upside here.
Expect RZLT to range from $13.99 to $33.62 through 2034. The $20.84 average target implies a +528% move from current prices. That is up +17% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The RZLT price prediction for 2035 points to an average of $22.79 (low $15.05, high $37.36) — a potential gain of +586% on today's $3.32. Momentum favours further upside here.
In 2040, RZLT is projected to trade between $25.06 and $71.80, averaging $41.00 — a potential gain of +11.3x from today's $3.32. That is up +80% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Rezolute, Inc.'s 2050 outlook centres on $87.18, within a $46.57 to $168.05 range. That is up +113% on the projected 2040 average. That marks a +25.3x change versus current levels. Momentum favours further upside here.
Investing $1,000 in RZLT today (≈ 301.204819 RZLT) could be worth
$26,259.36
+$25,259.36 (+2526%) by 2050 · US Dollar
Based on the average projected RZLT price of $87.18 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RZLTwould be worth at today's price.
$1,000 invested in RZLT on May 27, 2025 (≈ 261.096611 RZLT) would be worth
$866.84
-$133.16 (-13.3%) today · 0.87× · US Dollar
Based on a RZLT entry price of $3.83 vs. today's $3.32.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.22 | $1,031.06 | +3.1% |
| 1 month ago | $3.31 | $1,003.02 | +0.3% |
| 3 months ago | $3.29 | $1,009.12 | +0.9% |
| 6 months ago | $9.72 | $341.56 | -65.8% |
| 1 year ago | $3.83 | $866.84 | -13.3% |
| All time (5.0y) ago | $13.2 | $251.52 | -74.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RZLT forecast.
Our base-case forecast reaches $6.60 around 2028.
Implied market cap at $6.60: $635.53M
The long-run price outlook is bullish, with the avg price projected to rise from $3.25 in 2026 to higher levels by 2030 and beyond. In 2030 the avg is $9.77 with a max of $14.78 and a min of $6.99, and the ROI is 200.6 with a bullish sentiment. By 2040 the avg is $40.91 with a max of $73.13 and a min of $24.36, and the ROI is 1158.8 with a bullish sentiment.
By 2050 the avg is $86.31 with a max of $170.40 and a min of $44.34, and the ROI is 2555.7 with a bullish sentiment.
The forecast shows positive upside beyond 2026, with 2027 avg $5.90, 2028 avg $7.67, 2029 avg $8.66, and continued higher levels into 2031-2050. These projections are estimates and not guarantees, and long-term outcomes depend on multiple factors including clinical progress and market dynamics.
Tap a question to reveal the answer.
Avg: $9.77, Min: $6.99, Max: $14.78; ROI: 200.6; Sentiment: BULLISH.
Forecasts show bullish sentiment from 2027 onward, with positive upside in later years: 2027 Avg $5.90, 2028 Avg $7.67, 2029 Avg $8.66, 2030 Avg $9.77 and continuing higher through 2050 (Avg $86.31; Max $170.40). ROI figures become positive from 2027 onward (e.g., 81.4% in 2027, 200.6% in 2030, 2555.7% in 2050).
Yes. The 2040 forecast max is $73.13, and the 2030 max is $14.78, so a $50 level would be within the 2040 upside path according to the projections.
Current price: $3.25. Market cap: $312.95M. Rank: 3483.
Sentiment: BULLISH. RSI14: 50. SMA50: $3.15. SMA200: $5.45. Support: $3.07. Resistance: $3.61. 30-day range: $2.63–$4.02. Annualized volatility: 60%.
Rezolute, Inc. Community Discussion
0Share your Rezolute, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.